跳至主要内容
临床试验/JPRN-UMIN000012068
JPRN-UMIN000012068已完成未知

DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal Dysfunction - DIrect Effect of DPP-4 inhibitor and Renal Dysfunction

Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University0 个研究点目标入组 120 人开始时间: 2013年10月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

HbA1c reduction of teneligliptin and sitagliptin in 24-weeks was -0.69% and -0.65%, respectively, with no significant difference between the two groups.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnancy 2. Patients to whom contraindications in the Package Insert apply 3. Patients whose participation in the study is judged to be difficult for reasons such as reduced ability to understand, unstable mental state, and alcoholism 4. The patients with type 1 diabetes mellitus and secondary diabetes 5. Patients treated with insulin and oral hypoglycemic agents except SUs and BGs for more than 3 months 6. Patients who have concomitant malignant tumors, or who have been treated for malignant tumors within the past 5 years 7. Foreigners, patients belonging to Kyoto University and/or Kyoto University Hospital, patients who is participating clinical trials 8. Other patients whose participation is judged to be inappropriate by the responsible physician

研究者

发起方
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University

相似试验